   |
|
E-IJD® - CORRESPONDENCE |
|
| Year : 2022 | Volume
: 67
| Issue : 1 | Page : 94 |
|
| Epidermodysplasia verruciformis and breast cancer - Casual or Causal? |
|
|
Trinidad Montero-Vilchez, Antonio Martinez-Lopez, Andrea Rodriguez-Tejero, Jesus Tercedor-Sanchez, Alejandro Molina-Leyva, Salvador Arias-Santiago
Department of Dermatology at Hospital Universitario Virgen de las Nieves; Instituto de Investigación Biosanitaria ibs.GRANADA; Faculty of Medicine, University of Granada, Spain
| Date of Web Publication | 19-Apr-2022 |
Correspondence Address:
Alejandro Molina-Leyva
Department of Dermatology at Hospital Universitario Virgen de las Nieves; Instituto de Investigación Biosanitaria ibs.GRANADA; Faculty of Medicine, University of Granada
Spain
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijd.ijd_830_20
|
|
How to cite this article:
Montero-Vilchez T, Martinez-Lopez A, Rodriguez-Tejero A, Tercedor-Sanchez J, Molina-Leyva A, Arias-Santiago S. Epidermodysplasia verruciformis and breast cancer - Casual or Causal?. Indian J Dermatol 2022;67:94 |
How to cite this URL:
Montero-Vilchez T, Martinez-Lopez A, Rodriguez-Tejero A, Tercedor-Sanchez J, Molina-Leyva A, Arias-Santiago S. Epidermodysplasia verruciformis and breast cancer - Casual or Causal?. Indian J Dermatol [serial online] 2022 [cited 2023 Jun 4];67:94. Available from: https://www.e-ijd.org/text.asp?2022/67/1/94/343305 |
Sir,
Epidermodysplasia verruciformis (EV) is a rare dermatologic condition that manifests mainly as verrucous cutaneous lesions such as multiple persistent verrucae, pityriasis versicolor-like lesions and other verrucous or 'warty' cutaneous lesions. The immunity deficiency may be either primary, inherited in an autosomal recessive pattern or secondary, observed mainly in HIV-infected, immunocompromised or immunosuppressed individuals.[1] EV is characterised by a decreased immunologic ability to defend against and eradicate certain types of human papillomavirus (HPV), that are innocuous in the general population.[2] We describe for the first time, to our knowledge, a case of EV in relation to breast cancer in which EV lesions resolved after chemotherapy.
A 56-year-old woman presented to our Dermatology Clinic with a 28-year history of cutaneous lesions on her abdomen and lower limbs. She has no other disease and she did not take any medications. In her family history, one of her two brothers had the same findings but with less severe manifestations.
Physical examination revealed multiple brownish-hypopigmented papules scattered on her forehead, abdomen and lower limbs [Figure 1]a. Wood-lamp examination revealed a yellow fluorescence [Figure 1]b and [Figure 1]c. Skin biopsy taken from her abdomen showed epidermis acanthosis, and HPV-typing from a paraffin-embedded skin biopsy was positive for HPV-16. Consequently, the patient was diagnosed with EV and she started treatment with acitretin 10 mg once daily. After 2 years' follow-up, the lesions had not improved. Moreover, she was diagnosed with a breast cancer grade 3 in Bloom–Richardson system with oestrogen-receptor-negative, progesterone-receptor-negative and HER2 receptor positive, and was started on neoadjuvant chemotherapy therapy with docetaxel-trastuzumab-pertuzumab each 21 days. After four cycles of treatment, the patient presented a complete tumoral response. Moreover, EV lesions flattened out [Figure 2]. | Figure 1: (a) Multiple brownish-hypopigmented macules and papules scattered on lower limbs. (b) Multiple papules scattered on lower limbs with yellow fluorescence using a wood lamp. c) Multiple papules scattered on forehead with yellow fluorescence using a wood lamp
Click here to view |
 | Figure 2: Slight hypopigmented macules on (a) front and (b) lower limbs after chemotherapy
Click here to view |
EV is a dermatology condition in which there is widespread and persistent infection with different subtypes of HPV, leading to persistent infection and increased lifetime risk of development of cutaneous dysplasia and malignancy such as squamous cell carcinoma.[3] Nevertheless, the causal relationship between HPV and breast cancer is still controversial. Some molecular pathways regarding the implication of HPV infection being the aetiological factor for breast cancer carcinogenesis have been proposed. Cell surface to surface contact and the exposure of the mammary ducts to the external environment via the nipple-areola complex can provide the entry point for the HPV virus. Some reports suggested a hematogenic or lymphatic transfer of HPV viruses from one organ to another, while other studies indicated that the virus exists in nipple tissues and breast milk, showing that HPV can transfer from the nipple-areola complex to lactiferous ducts.[4] Moreover, the latest meta-analysis between this association showed an increased risk of breast cancer in HPV DNA-positive individuals.[5]
In our patient, the good clinical response of EV lesions to chemotherapy makes this biological association plausible and opens new fields of research on EV treatments. However, a casual clinical improvement could not be dismissed. In conclusion, up to our knowledge, we present for the first time a case of EV in relation to breast cancer with a good clinical response after docetaxel-trastuzumab-pertuzumab chemotherapy.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
 References | |  |
| 1. | Huang S, Wu JH, Lewis DJ, Rady PL, Tyring SK. A novel approach to the classification of epidermodysplasia verruciformis. Int J Dermatol 2018;57:1344-50.  |
| 2. | Przybyszewska J, Zlotogorski A, Ramot Y. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate. J Am Acad Dermatol 2017;76:1161-75. |
| 3. | Al Rubaie S, Breuer J, Inshasi J, Al Saady S, Fathi I. Epidermodysplasia verruciformis with neurological manifestations. Int J Dermatol 1998;37:766-71. |
| 4. | De Carolis S, Storci G, Ceccarelli C, Savini C, Gallucci L, Sansone P, et al. HPV DNA associates with breast cancer malignancy and it is transferred to breast cancer stromal cells by extracellular vesicles. Front Onco 2019;9:860. doi: 10.3389/fonc.2019.00860. |
| 5. | Kudela E, Nachajova M, Danko J. Is the HPV virus responsible for the development of breast cancer? Breast J 2019;25:1053-4. |
[Figure 1], [Figure 2] |
|
|
|
|
|
|
|
|
|
|
|
|
| Article Access Statistics | | | Viewed | 1272 | | | Printed | 28 | | | Emailed | 0 | | | PDF Downloaded | 8 | | | Comments | [Add] | | |
|
|
